Scholar Rock is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapies for serious diseases with significant unmet needs. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily, Scholar Rock focuses on advancing treatments for conditions such as neuromuscular diseases, cardiometabolic disorders, and cancer. The company is recognized for its pioneering work in muscle-targeted therapies, particularly in spinal muscular atrophy (SMA), and utilizes a proprietary platform to create novel monoclonal antibodies that selectively modulate protein growth factors. With a commitment to addressing historically under-treated disease areas, Scholar Rock aims to transform patient care through cutting-edge science and a robust pipeline of potential therapies.
The MSL/Sr MSL role involves representing KOL/HCP input for product development and conducting clinical presentations.
The Director/Sr Director of Pharmacovigilance Operations leads the management of pharmacovigilance activities, ensuring compliance and efficiency in operations.
The Associate Director, Regulatory Labeling will lead the development and maintenance of global product labeling strategies for biopharmaceutical products.
The Senior Manager, Medical Writing will oversee document development and manage medical writing activities for drug marketing applications.
The Medical Science Liaison will engage with KOLs and conduct clinical presentations, focusing on innovative treatments for neuromuscular diseases.
The Senior Director, Global Value & Access will lead market access strategies for the launch of apitegromab in spinal muscular atrophy across Europe and other key markets.
No More Jobs Found